All In Biotech

Drug Trial Radar · NCT06943755

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 440 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

440

Planned (sponsor's estimate)

Start

Jul 21, 2025

Primary completion

Jun 30, 2029

Study completion Jun 30, 2029

Sponsor

Lead sponsor
ExelixisIndustry
Sponsor type
Industry
First posted
Apr 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors.

Conditions

  • Pancreatic Neuroendocrine Tumor (pNET)
  • Extra-Pancreatic Neuroendocrine Tumor (epNET)

Interventions

  • ZanzalintinibDrug

    Administered as specified in the treatment arm.

  • EverolimusDrug

    Administered as specified in the treatment arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors Version (RECIST) 1.1 as Assessed by Blinded Independent Central Review (BICR)Time frame: Up to 48 months

Locations

135 sites in 18 countries. Site status is shown where the registry gives one.

  • The University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Mayo Clinic Hospital

    Phoenix, Arizona · Recruiting

  • The University of Arizona Cancer Center

    Tucson, Arizona · Recruiting

  • Cedars-Sinai Medical Center

    Beverly Hills, California · Recruiting

  • Norris Comprehensive Cancer Center

    Los Angeles, California · Recruiting

  • Stanford Cancer Center

    Palo Alto, California · Recruiting

  • UCLA Health - Santa Monica Cancer Care

    Santa Monica, California · Recruiting

  • Kaiser Permanente Medical Center

    Vallejo, California · Recruiting

  • Georgetown University

    Washington D.C., District of Columbia · Recruiting

  • Mayo Clinic - Florida

    Jacksonville, Florida · Recruiting

  • AdventHealth Orlando

    Orlando, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • University of Kentucky Markey Cancer Center

    Lexington, Kentucky · Recruiting

  • East Jefferson General Hospital

    Metairie, Louisiana · Recruiting

  • National Institute of Health

    Bethesda, Maryland · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Henry Ford Cancer- Detroit

    Detroit, Michigan · Recruiting

  • The Cancer and Hematology Centers

    Grand Rapids, Michigan · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Siteman Cancer Center

    St Louis, Missouri · Recruiting

  • University of Nebraska Medical Center

    Omaha, Nebraska · Recruiting

  • University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico · Recruiting

  • Roswell Park Cancer Institute

    Buffalo, New York · Recruiting

  • Icahan School of Medicine at Mount Sinai

    New York, New York · Recruiting

  • University of Rochester Medical Center

    Rochester, New York · Recruiting

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Sanford Roger Maris Cancer Center

    Fargo, North Dakota · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center

    Pittsburgh, Pennsylvania · Recruiting

  • University of Tennessee Medical Center

    Knoxville, Tennessee · Recruiting

  • Henry-Joyce Cancer Clinic

    Nashville, Tennessee · Recruiting

  • Texas Oncology- Baylor Charles A. Sammons Cancer Center

    Dallas, Texas · Recruiting

  • Huntsman Cancer Institute, University of Utah

    Salt Lake City, Utah · Recruiting

  • University of Virginia

    Charlottesville, Virginia · Recruiting

  • Virginia Cancer Specialists - Fairfax Office

    Fairfax, Virginia · Recruiting

  • Fred Hutchinson Cancer Center

    Seattle, Washington · Recruiting

Showing 40 of 135 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.